ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME

ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME was reported 208 times

These drug classes are most commonly taken by patients reporting ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME:

# Drug Count
0 Retinoid [EPC] 82
1 Corticosteroid [EPC] 34
2 Nucleoside Metabolic Inhibitor [EPC] 34
3 Folate Analog Metabolic Inhibitor [EPC] 23
4 Azole Antifungal [EPC] 17
5 Xanthine Oxidase Inhibitor [EPC] 13
6 Glycopeptide Antibacterial [EPC] 11
7 Antimetabolite [EPC] 9
8 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 8
9 Sulfonamide Antimicrobial [EPC] 8
10 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7
11 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7
12 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7
13 Loop Diuretic [EPC] 7
14 Calcium Channel Blocker [EPC] 6
15 Dihydropyridine Calcium Channel Blocker [EPC] 6
16 Proton Pump Inhibitor [EPC] 6
17 Benzodiazepine [EPC] 5
18 Echinocandin Antifungal [EPC] 5
19 Insulin Analog [EPC] 5
20 Serotonin-3 Receptor Antagonist [EPC] 5
21 Penem Antibacterial [EPC] 4
22 Polyene Antifungal [EPC] 4
23 General Anesthetic [EPC] 3
24 Histamine-2 Receptor Antagonist [EPC] 3
25 Lipid-based Polyene Antifungal [EPC] 3
26 Oxazolidinone Antibacterial [EPC] 3
27 Topoisomerase Inhibitor [EPC] 3
28 Alkylating Drug [EPC] 2
29 Antifibrinolytic Agent [EPC] 2
30 Histamine-1 Receptor Antagonist [EPC] 2
31 Nitroimidazole Antimicrobial [EPC] 2
32 Nonsteroidal Anti-inflammatory Drug [EPC] 2
33 Platelet Aggregation Inhibitor [EPC] 2
34 Angiotensin Converting Enzyme Inhibitor [EPC] 1
35 Calcineurin Inhibitor Immunosuppressant [EPC] 1
36 Fluoroquinolone Antibacterial [EPC] 1
37 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
38 Opioid Agonist [EPC] 1
39 Prostaglandin Analog [EPC] 1
40 Provitamin D2 Compound [EPC] 1
41 beta-Adrenergic Blocker [EPC] 1